Massimiliano Mistrangelo Selected Research

Anus Neoplasms (Anal Cancer)

5/2021	Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II Trial.
1/2019	Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier).
9/2018	Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.
6/2018	Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.
5/2018	The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.
4/2017	Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.
12/2016	Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation.
7/2016	Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.
4/2016	Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.
4/2016	Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Massimiliano Mistrangelo Research Topics

Disease

12	Anus Neoplasms (Anal Cancer) 05/2021 - 07/2015
8	Neoplasms (Cancer) 01/2022 - 11/2007
4	Rectal Neoplasms (Rectal Cancer) 01/2021 - 01/2015
3	Anastomotic Leak 10/2021 - 01/2021
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 05/2018
3	Hemorrhage 01/2021 - 04/2016
1	Surgical Wound Infection 10/2021
1	Proctitis 01/2021
1	Sepsis (Septicemia) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Fistula 01/2021
1	Hemorrhoids 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Portal Hypertension 01/2021
1	Abscess 01/2021
1	Diarrhea 10/2020
1	Crohn Disease (Crohn's Disease) 10/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2020
1	Celiac Disease (Celiac Sprue) 10/2020
1	Ischemia 09/2020
1	Intraoperative Complications 11/2019
1	Inflammation (Inflammations) 01/2019
1	Warts (Wart) 02/2018
1	Postoperative Pain 01/2018
1	Pain (Aches) 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Edema (Dropsy) 01/2018
1	Endometriosis 04/2014
1	Cicatrix (Scar) 04/2014
1	Obesity 07/2013
1	Flatulence 07/2013
1	Urinary Incontinence 07/2013
1	Breast Neoplasms (Breast Cancer) 11/2011
1	Neoplasm Metastasis (Metastasis) 11/2011
1	Colorectal Neoplasms (Colorectal Cancer) 11/2007

Drug/Important Bio-Agent (IBA)

2	Mitomycin (Mitomycin-C)FDA LinkGeneric 09/2018 - 05/2018
2	Fluorouracil (Carac)FDA LinkGeneric 09/2018 - 05/2018
1	Bacitracin (Baci-Rx)FDA LinkGeneric 10/2021
1	beta-Lactamases (beta-Lactamase)IBA 10/2021
1	beta-LactamsIBA 10/2021
1	Neomycin FDA LinkGeneric 10/2021
1	RacivirIBA 10/2020
1	Emtricitabine (Emtriva)FDA Link 10/2020
1	Tenofovir (Viread)FDA Link 10/2020
1	Capecitabine (Xeloda)FDA Link 09/2018
1	Indicators and Reagents (Reagents)IBA 05/2018
1	Hemoglobins (Hemoglobin)IBA 05/2018
1	Antiviral Agents (Antivirals)IBA 02/2018
1	TabletsIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Ketorolac Tromethamine (Acular)FDA LinkGeneric 01/2018
1	mesoglycanIBA 01/2018
1	SolutionsIBA 01/2016
1	Hormones (Hormone)IBA 11/2011
1	Coloring Agents (Dyes)IBA 11/2007
1	sulfan blue (patent blue V)IBA 11/2007

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 06/2018 - 07/2015
7	Radiotherapy 01/2021 - 01/2015
6	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 05/2021 - 07/2015
4	Therapeutics 01/2021 - 11/2011
2	Neoadjuvant Therapy 01/2022 - 01/2015
2	Length of Stay 02/2021 - 10/2016
2	Hemorrhoidectomy 01/2021 - 01/2018
2	Operative Time 11/2019 - 04/2016
2	Conversion to Open Surgery 10/2018 - 10/2016
1	Antibiotic Prophylaxis 10/2021
1	Adjuvant Chemotherapy 01/2021
1	Conservative Treatment 01/2021
1	Ileostomy 01/2021
1	Gastrectomy 10/2020
1	Chemoradiotherapy 01/2019
1	Diathermy 01/2018
1	Pain Management 01/2018
1	Colostomy 01/2016
1	Cesarean Section (Caesarean Section) 04/2014
1	Bariatric Surgery 07/2013
1	Radical Mastectomy 11/2011